Patent · US Expired

Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof

US7291335B2 · kind B2 · utility

1Cited by

2References

7Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Elisabeth Stockert · New York, US
Elke Jager · Frankfurt am Main, DE
Yao-Tseng Chen · New York, US
Matthew Scanlan · Princeton Junction, US
Alexander Knuth · Frankfurt am Main, DE
Lloyd J. Old · New York, US

Key dates

Filing date	Dec 17, 2001
Grant date	Nov 6, 2007
Priority date	—
Expiry date	Sep 27, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K39/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies which bind to the cancer associated antigen NY-ESO-1. Both polyclonal and monoclonal antibodies are part of the invention, as are chimeric forms of the antibodies, and binding portions of antibodies. Uses of these antibodies are described. Also described are truncated, recombinant forms of the cancer associated antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.